Faced with heavy criticism over its handling of a series of drug safety crises in the past year, the FDA is exploring ways in which it can more effectively warn physicians and the public about prescription drug safety problems. The agency is holding a two-day hearing this week to look at ways which technology and other measures can be used to track potential problems and spread the word about new information regarding risks.
- see this article from the Financial Times